Press release
The companion diagnostics (CDx) market is projected to grow with a good CAGR during the forecast period 2018-2023
The recent study on the companion diagnostics market covers an in-depth analysis of the market on the basis of technology, indication, and geography. The report also covers the country level analysis within the regions as well. In addition, the report covers the key trends in the market along with drivers and restraints during the forecast period 2018-2023. According to the report titled “Companion Diagnostics (CDx) Market - Forecasts From 2018 TO 2023”, the market is expected to surge at a substantial annual growth rate during the projected period. The report has segmented the CDx market by technology (Polymerase Chain Reaction, Immunohistochemistry, In-situ Hybridization, Next Generation Sequencing), indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Other Oncology, non-oncology diseases), geography (North America, South America, Europe, Middle East and Africa, Asia Pacific). The companion diagnostics find use in identification of patients who are most likely to be benefitted from a therapeutic product, identification of patients who are likely to be at an increased risk of getting serious side effects and monitoring treatment response of a therapeutic product in order to achieve safety and efficacy of the treatment. The market is currently at a nascent stage but is poised to show strong growth during the forecast period owing to help companies in identifying the need of the companion drugs in the drug development process in addition to growing research and development activities. The growing trend of personalized medicine and the growing incidences of cancer will further boost the growth of the global CDx market. Furthermore, rising healthcare expenditure, technological advancements, and growing pharmaceutical industry are also driving the market growth.Request Sample: www.knowledge-sourcing.com/requestsample&sample_id=1983
Growing incidences of cancer worldwide is one of the significant contributors in driving the market growth during the forecast period and beyond.
According to the Cancer Research UK, the worldwide cancer incidence statistics state that there are 17 million new cases of cancer in 2018, the new cases of cancer comprises of more than 4 out of ten cases which are as follows: lung cancer, female breast, bowel, or prostate cancer. In addition, the worldwide cancer incidence rates are projected to increase by more than 62% by 2030.
Companion diagnostics are being utilized in view of the evolving cancer care where the researchers are devoting huge resources in the development of companion diagnostics in order to provide targeted therapies to improve the survival rates in patients suffering from cancer. Many oncologists and cancer care professionals have recognized that some cancer drugs are more effective among individuals with specific tumor molecular characteristics, thus, calling for the need of companion diagnostics, which may be more critical as the cancers are being increasingly subdivided on the basis of their molecular characteristics.
North America is expected to hold the largest market share.
The North America companion diagnostics market is expected to hold a major market share during the forecast period. This is due to the technological advancements in the companion diagnostics, high healthcare expenditure by the United States, early adoption of innovation, and a high level of awareness among the people regarding companion diagnostics. In addition, many key market players are based in this region, thus are collaborating with each other regarding the research and development activities in companion diagnostics. Furthermore, companies are also collaborating with each other in order to expand the global reach and delivery of companion diagnostics in the region.
Some of the major players discussed in the reports are Abbott Laboratories, Agilent Technologies, Inc., and F. Hoffmann-La Roche Ltd., among others.
Request customization or place an order: www.knowledge-sourcing.com/companion-diagnostics-cdx-market
About Us:
Knowledge Sourcing Intelligence (KSI) is a market research and consulting organization based out of India. KSI publishes research studies spanning across ten industry verticals. KSI has a team of experienced and young professionals with a singular focus on delivering high-quality research services to enterprises, non-government organizations, government agencies, and research institutes and organizations. We publish hundreds of reports per year centering on niche and latest technologies. We engage with key decision makers and stakeholders across the value chain to provide clients with a detailed analysis and bird’s-eye view of the market with whole market dynamics, statistical forecasts, competitive analysis, key trends, market drivers and challenges and strategic recommendations for making informed decisions. Our success lies in the effort of our analysts who strive to meet client expectations by delivering quality work within the stipulated deadlines.
Contact:
Knowledge Sourcing Intelligence LLP
2nd Floor, D-77, Sector 63
Noida, U.P. - 201301
India
E: sales@knowledge-sourcing.com | P: +1-866-714-4587
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The companion diagnostics (CDx) market is projected to grow with a good CAGR during the forecast period 2018-2023 here
News-ID: 1620655 • Views: …
More Releases from Knowledge Sourcing Intelligence LLP
Microcarrier Market is projected to surpass US$1,989.084 million by 2029 at a CA …
According to a new study published by Knowledge Sourcing Intelligence, the microcarrier market is projected to grow at a CAGR of 11.55% between 2022 and 2029 to reach US$1,989.084 million by 2029.
An aid matrix called a microcarrier allows more adherent cells to enter bioreactors. In the large-scale commercial production of biologics and vaccines, microcarriers cultivate adherent cellular populations that produce viruses or proteins. The scope of this document states…
Feed Grade Threonine Market Size, Trends, In-depth Analysis, Research Report For …
Knowledge Sourcing Intelligence announces the publication of a new analysis report on the market of "feed-grade threonine market - which is forecasted from 2023 to 2028".
The feed-grade threonine market is estimated to grow at a CAGR of 5.12% during the forecast period.
With both quantitative and qualitative analysis, this study intends to offer an in-depth assessment of the feed-grade threonine market. This will further help to establish business and growth plans…
Global Horse Feed Market Size, Trends, In-depth Analysis, Research Report Foreca …
Knowledge Sourcing Intelligence announces the publication of a new analysis report on the market of "global horse feed market - which is forecasted from 2023 to 2028".
The global horse feed market is estimated to grow at a CAGR of 4.93% during the forecast period.
With both quantitative and qualitative analysis, this study intends to offer an in-depth assessment of the global horse feed market. This will further help to establish business…
Wheat Seed Treatment Market Size, Trends, In-depth Analysis, Research Report For …
Knowledge Sourcing Intelligence announces the publication of a new analysis report on the market of "wheat seed treatment market - which is forecasted from 2023 to 2028".
The Wheat seed Treatment market is estimated to grow at a CAGR of 7.49% during the forecast period.
With both quantitative and qualitative analysis, this study intends to offer an in-depth assessment of the wheat seed treatment market. This will further help to establish business…
More Releases for CDx
Companion Diagnostic (CDx) Market Outlook & Growth Prediction 2022 By Leading Pl …
Stratagem Market Insights recently published a research report titled, "Companion Diagnostic (CDx) Market - Increase in Demand and Opportunities 2022". The research report attempts to give a holistic overview of the Companion Diagnostic (CDx) market by keeping the information simple, relevant, accurate, and to the point. The research report highlights the inner and outer examination of the Companion Diagnostic (CDx) market. This intelligence report includes investigations based on Current scenarios,…
Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market …
The Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research.
The Pharmacogenomics Technology…
Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market …
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) market survey report has been prepared by conducting market research in a…
Pharmacogenomics Technology (Theranostics & Cdx) Market 2021 Analysis by Size, S …
This comprehensive Report on the Pharmacogenomics Technology (Theranostics & Cdx) Market provides real information about the statistics and state of the global and regional market. Its scope study extends from the market situation to comparative pricing between the main players, spending in specific market areas, and profits. It represents a comprehensive and succinct analysis report of the main competitor and price statistics with a view to helping beginners establish their…
Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Mark …
This report studies the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market by companies, region, type and end-use industry.
Get Sample Copy of This Report @ https://www.researchtrades.com/request-sample/1644663
In 2017, the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market size was million US$ and it is expected to reach million US$ by the end of 2025,…
Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Sale …
This report studies the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market, analyzes and researches the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like
Qiagen NV
GE Healthcare
Agilent Technologies
F Hoffman La Roche
Foundation Medicine
Thermo Fisher Scientific Inc.
Leica Biosystems Nussloch GmBH
Pfizer
Get the sample copy of report : https://www.marketresearchreports.biz/sample/sample/1486733
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast…